Hypochondroplasia, achondroplasia, and thanatophoric dysplasia caused by mutations of the fibroblast-growth-factor-receptor-3-gene (FGFR 3);Hypochondroplasie, achondroplasie und thanatophore dysplasie als folge von mutationen des fibroblastenwachstumsfaktor-rezeptor-3-gens (FGFR3)

Monatsschrift fur Kinderheilkunde

Volumn 146, Issue 7, 1998, Pages 687-691

  Hilbert, M ^a,b   Hilbert, K ^a   Spranger, J ^a   Wildhardt, G ^a   Winterpacht, A ^a   Wuchner C ^a   Zabel, B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Achondroplasia; FGFR3; Hypochondroplasia; Mutations; Thanatophoric dysplasia

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR;

ACHONDROPLASIA; ARTICLE; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HYPOCHONDROPLASIA; MAJOR CLINICAL STUDY; THANATOPHORIC DWARFISM;

EID: 0031904581     PISSN: 00269298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001120050312     Document Type: Article

References (21)

1. Bellus GA, Gaudenz K, Zackai EH, Clarke LA, Szabo J, Francomano CA, Muenke M (1996) Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat Genet 14:174-176
2. Bellus GA, Hefferon TW, Ortiz de Luna RI, Hecht JT, Horton WA, Machado M, Kaitila I, McIntosh I, Francomano CA (1995) Achondroplasia is defined by recurrent G380R mutations in FGFR3. Am J Hum Genet 56:368-373
3. Bellus GA, McIntosh I, Smith EA, Aylsworth AS, Kaitila I, Horton WA, Greenhaw GA, Hecht JT, Francomano CA (1995) A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 (FGFR3). Nat Genet 10:357-359
4. Chesi M, Nardini E, Brents LA, Schrack E, Ried T, Kuehl WM, Bergsagel PL (1997) Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16:260-264
5. S. Hall BD, Spranger J (1979) Hypochondrodysplasia: clinical and radiological aspects in 39 cases. Am J Hum Genet 133:95-100
6. Ikegawa S, Fukushima Y, Isomura M, Takada F, Nakamura Y (1995) Mutations in the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients. Hum Genet 96:309-311
7. Johnson DE, Willams LT (1993) Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 60:1-41
8. Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW (1995) Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Gene: 11 462-464
9. Naski MC, Wang Q, XU J, Ornitz DM (1996) Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat Genet 13:233-237
10. Peters K, Ornitz D, Werner S, Williams L (1993) Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev Biol 155:423-430
11. Pokhrel RK, Alimsardjono H, Takeshima Y, Nakamura H, Naritomi K, Hirose S, Onishi S, Matsuo M (1996) Japanese cases of type 1 thanatophoric dysplasia exclusively carry a C to T transition at nucleotide 742 of the fibroblast growth factor receptor 3 gene. Biochem Biophys Res Commun 227:236-239
12. Prinos P, Costa T, Sommer A, Kilpatrick MW, Tsipouras P (1995) A common FGFR3 gene mutations in hypochondroplasia. Hum Mol Genet 4:2097-2101
13. Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet J-M, Maroreaux P, Le Merre M, Munich A (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371:252-254
14. Roussau F, Bonaventure J, Legeai-Mallet L, Schmidt H, Weissenbach J, Maroteaux P, Munnich A, Le Merrer M (1996) Clinical and genetic heterogeneity of hypochondroplasia. J Med Genet 33:749-752
15. Rousseau F, Saugier P, Le Merrer M, Munnich A, Delezoide A-L, Maroteaux P, Bonaventure J (1995) Stop codon FGFR3 mutation in thanatophoric dwarfism type 1. Nat Genet 10:11-12
16. Shiang R, Thompson LM, Zhu Y-Z, Church DM, Fiedler TJ, Bocian M, Winokur ST, Wasmuth JJ (1994) Mutations in the transmembrane domain of FGFR-3 causes the most common genetic form of dwarfism, achondroplasia. Cell 78:335-342
17. Spranger J (1988) Bone dysplasia "families" Pathol Immunpathol Res 7:76-80
18. Spranger J, Langer LO, Wiedemann H-R (1974) Bone dysplasias. An atlas of constitutional disorders of skeletal development. Fischer & Saunders, Stuttgart Philadelphia
19. Superti-Furga A, Eich GU, Bucher H, Wisser J, Gideon A, Gitzeimann R, Steinmann B (1995) A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia. Eur J Pediatr 95:215-219
20. Tavormina PL, Shiang R, Thompson LM, Zhu Y-Z, Wilkin DJ, Lachman RS, Wilcox WR, Rimoin DL, Cohn DH, Wasmuth JJ (1995) Thanatophoric dysplasia (types I and II) caused by distinct mutations in the fibroblast growth factor receptor 3. Nat Genet 9:321-328
21. Wildes D, Rutland P, Pulleyn W, Moss C, Ellis JP, Winter RM, Malcom S (1996) A recurrent mutation, ala391glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans. J Med Genet 33:744-748